A reliable and inexpensive EasyCD4 assay for monitoring HIV-infected individuals in resource-limited settings

Journal of Acquired Immune Deficiency Syndromes

Volumn 43, Issue 1, 2006, Pages 23-26

  Balakrishnan, Pachamuthu ^a   Solomon, Suniti ^a   Mohanakrishnan, Janardhanan ^a   Cecelia, Anitha J ^a   Kumarasamy, Nagalingeswaran ^a   Murugavel, Kailapuri G ^a   Venkatakrishnan, Bhavani ^a   Solomon, Sunil S ^a   Crowe, Suzanne M ^b   Ganesh, Aylur K ^a   Thyagarajan, Sadras P ^c   Flanigan, Timothy ^d   Mayer, Kenneth H ^d  

^a YRG CENTRE FOR AIDS RESEARCH AND EDUCATION   (India)

^b MACFARLANE BURNET INSTITUTE FOR MEDICAL RESEARCH AND PUBLIC HEALTH   (Australia)

^c UNIVERSITY OF MADRAS   (India)

^d BROWN UNIVERSITY   (United States)

Author keywords

CD4 T lymphocyte count; EasyCD4 assay; Flow cytometry; Guava technologies; HIV monitoring; Low cost CD4; Resource limited setting

Indexed keywords

EDETIC ACID;

ADOLESCENT; ADULT; ARTICLE; BLOOD ANALYSIS; BLOOD SAMPLING; CD4 LYMPHOCYTE COUNT; CHILD; COMPARATIVE STUDY; COST MINIMIZATION ANALYSIS; COURSE EVALUATION; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; FEMALE; FLOW CYTOMETRY; FLUORESCENCE ACTIVATED CELL SORTING; FOLLOW UP; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOCYTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; PATIENT MONITORING; PRIORITY JOURNAL; RELIABILITY;

ADOLESCENT; ADULT; CD4 LYMPHOCYTE COUNT; CHILD; COSTS AND COST ANALYSIS; FLOW CYTOMETRY; HIV INFECTIONS; HUMANS; INDIA; MIDDLE AGED; MONITORING, IMMUNOLOGIC; REPRODUCIBILITY OF RESULTS; RESOURCE ALLOCATION;

EID: 33748092700     PISSN: 15254135     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.qai.0000227791.92203.d5     Document Type: Article

References (15)

1. WHO 2004. Scaling up antiretroviral therapy in resource-limited settings: treatment guidelines for a public health approach. World Health Organisation, Geneva. 2004. Available at: http://www.who.int/hiv/pub/prev_care/en/ arvrevision2003en.pdf. Accessed on March 12, 2006.
2. + lymphocyte counts determined by enzyme immunoassay (TRAx CD4 test kit) and flow cytometry. Clin Diagn Lab Immunol. 1996;3(4):371-373.
3. + T-lymphocyte enumeration for implementation in developing countries. J Acquir Immune Defic Syndr. 2001;26:193-195.
4. Nicholson JK, Velleca WM, Jubert S, et al. Evaluation of alternative CD4 technologies for the enumeration of CD4 lymphocytes. J Immunol Methods. 1994;28:43-54.
5. Balakrishnan P, Dunne Mandy, Kumarasamy N, et al. An inexpensive, simple and manual method of CD4 T-cell quantitation in HIV-infected individuals for use in developing countries. J Acquir Immune Defic Syndr. 2004;36:1006-1010.
6. Forum for Collaborative HIV Research. A meeting organized by the forum for collaborative HIV research: Transfer of HIV diagnostic and monitoring technologies into resource-poor settings. Washington, DC, April 22, 2002.
7. Kumarasamy N, Mahajan AP, Flanigan TP, et al. Total lymphocyte count (TLC) is a useful tool for the timing of opportunistic infection prophylaxis in India and other resource-constrained countries. J Acquir Immune Defic Syndr. 2002;31(4):378-383.
8. + T lymphocytes in resource-limited settings: the ANRS 12-26 study. AIDS. 2003;17(15):2201-2208.
9. Crowe S, Turnbull S, Oelrichs R, et al. Monitoring of human immunodeficiency virus infection in resource-constrained countries. Clin Infect Dis. 2003;37(suppl 1):S25-S35.
10. Guava EasyCD4 Software, Version 2.2. Guava EasyCD4 System User's Guide. CA: Guava Technologies Inc; May 2004.
11. Jeyaseelan L, Rao PSS. Statistical measures of clinical agreement. Natl Med J India. 1992;5(6):286-290.
12. Bland JM, Altman DG. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet. 1986;1:307-310.
13. Scott L, Lawrie D, Harvey J, et al. A comparison of the guava personal cell analyser with PLG CD4 T-cell enumeration: a pilot evaluation. Paper presented at: 11th Conference on Retroviruses and Opportunistic Infections; February 8-11, 2004; San Francisco, CA. Abstract 962.
14. + T-cell counts in HIV-1-seropositive and -seronegative volunteers. Paper presented at: 11th Conference on Retroviruses and Opportunistic Infections; February 8-11, 2004; San Francisco, CA. Abstract 961.
15. + T cells. Paper presented at: 12th Conference on Retroviruses and Opportunistic Infections; February 22-25, 2005; Boston, MA. Abstract 741.